Basic Information
| LncRNA/CircRNA Name | circUBAP2 |
| Synonyms | |
| Region | |
| Ensemble | |
| Refseq |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | ovarian cancer |
| ICD-0-3 | C56.9 |
| Methods | qPCR, CCK-9 and transwell assays |
| Sample | ovarian cancer tissues and cell lines |
| Expression Pattern | up-regulated |
| Function Description | circUBAP2 was highly expressed in OC tissues, and its expression was negatively correlated with TMN stage and five-year survival of OC patients. Overexpression of circUBAP2 significantly promoted the proliferative and migratory abilities of OC cells. |
| Pubmed ID | 31539115 |
| Year | 2019 |
| Title | CircRNA UBAP2 Promotes the Progression of Ovarian Cancer by Sponging microRNA-144 |
External Links
| Links for circUBAP2 | GenBank HGNC NONCODE |
| Links for ovarian cancer | OMIM COSMIC |